INS and type 2 diabetes mellitus: Finally, SCFA-supplemented mice showed significantly lower homeostatic model assessment of HOMA-IR (Figure 1(h)) than T2D controls and enhanced insulin sensitivity, without affecting the FINS (Figure 1(g)).